Enhanced Efficacy of Neoadjuvant Chemotherapy with Nab-Paclitaxel and Platinum for Locally Advanced Cervical Cancer

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.2165433433946
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram L, Dikshit R, et al. Cancer incidence andmortality worldwide: sources, methods and major patterns in GLOBOCAN2012. Int J Cancer. 2015;136(5):E359–86. doi:10.1002/ijc.2921025220842
   PubMed Web of Science ®Google Scholar
• Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(15):1144–1153. doi:10.1056/NEJM19990415340150210202165
   PubMed Web of Science ®Google Scholar
• Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340(15):1137–1143. doi:10.1056/NEJM19990415340150110202164
   PubMed Web of Science ®Google Scholar
• Lanciano R, Calkins A, Bundy BN, et al. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvicradiation in advanced cervix cancer: a gynecologic oncology group study. J Clin Oncol. 2005;23(33):8289–8295. doi:10.1200/JCO.2004.00.049716230678
   PubMed Web of Science ®Google Scholar
• Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: asystematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26(35):5802–5812. doi:10.1200/JCO.2008.16.436819001332
   PubMed Web of Science ®Google Scholar
• Wang YM, Wang CJ, Fang FM, et al. Differences in the outcomes and complications between elderly and younger uterine cervical cancer patients treated by definitive radiotherapy - A propensity score-matched study. Gynecol Oncol. 2017;145(2):277–283. doi:10.1016/j.ygyno.2017.02.03428274568
   PubMed Web of Science ®Google Scholar
• da Costa SCS, Bonadio RC, GabrielliF CG, et al. Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation versus chemoradiation for locally advanced cervical cancer: a randomized Phase II trial. J Clin Oncol. 2019;37(33):3124–3131. doi:10.1200/JCO.19.0067431449470
   PubMed Web of Science ®Google Scholar
• Mougalian SS, Soulos PR, Killelea BK, et al. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States. Cancer. 2015;121(15):2544–2552. doi:10.1002/cncr.2934825902916
   PubMed Web of Science ®Google Scholar
• Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12(7):681–692. doi:10.1016/S1470-2045(11)70142-521684205
   PubMed Web of Science ®Google Scholar
• Tesfai FM, Kroep JR, Gaarenstroom K, et al. Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy. Int J Gynecol Cancer. 2020;30(1):115–121. doi:10.1136/ijgc-2019-00064731744889
   PubMed Web of Science ®Google Scholar
• Fröbe A, Jones G, Bokulić T, et al. High-dose-rate brachytherapy and concurrent chemoradiotherapy followed by surgery for stage Ib-IIb cervical cancer: single institution experience. Anticancer Res. 2014;34(7):3861–3866.24982415
   PubMed Web of Science ®Google Scholar
• Gupta S, Maheshwari A, Parab P, et al. Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial. J Clin Oncol. 2018;36(16):1548–1555. doi:10.1200/JCO.2017.75.998529432076
   PubMed Web of Science ®Google Scholar
• Zhao P, Wang Y, Wu AH, et al. Roles of albumin-binding proteins in cancer progression and biomimetic targeted drug delivery. Chembiochem. 2018;19(17):1796–1805. doi:10.1002/cbic.20180020129920893
   PubMed Web of Science ®Google Scholar
• Chen N, Brachmann C, Liu XP, et al. Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration. Cancer Chemother Pharmacol. 2015;76(4):699–712. doi:10.1007/s00280-015-2833-526231955
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247. doi:10.1016/j.ejca.2008.10.02619097774
   PubMed Web of Science ®Google Scholar
• Stone A, Wheeler C, Carroll K, et al. Optimizing randomized phase II trials assessing tumor progression. Contemp Clin Trials. 2007;28(2):146–152. doi:10.1016/j.cct.2006.05.00316807129
   PubMed Web of Science ®Google Scholar
• Dancey JE, Dodd LE, Ford R, et al. Recommendations for the assessment of progression in randomised clinical trials. Eur J Cancer. 2009;45(2):281–289. doi:10.1016/j.ejca.2008.10.04219097775
   PubMed Web of Science ®Google Scholar
• McCormack M, Kadalayil L, Hackshaw A, et al. A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. Br J Cancer. 2013;108(12):2464–2469. doi:10.1038/bjc.2013.23023695016
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang G, Wei LH, et al. Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement. Chin J Cancer. 2011;30(9):645–654. doi:10.5732/cjc.011.1005021880186
   PubMedGoogle Scholar
• Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer. 2003;39(17):2470–2486. doi:10.1016/S0959-8049(03)00425-814602133
   PubMed Web of Science ®Google Scholar
• Zhu YS, Yang JH, Zhang X, et al. Acquired treatment response from neoadjuvant chemotherapy predicts a favorable prognosis for local advanced cervical cancer: a meta-analysis. Medicine. 2018;97(17):e0530. doi:10.1097/MD.000000000001053029703026
   PubMed Web of Science ®Google Scholar
• Panici PB, Scambia G, Greggi S, et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: a pilot study. Obstet Gynecol. 1988;71(3 Pt 1):344–348.2450323
   PubMed Web of Science ®Google Scholar
• Huang YH, Liu L, Cai J, et al. The efficacy and response predictors of platinum-based neoadjuvant chemotherapy in locally advanced cervical cancer. Cancer Manag Res. 2020;12:10469–10477. doi:10.2147/CMAR.S27025833122946
   PubMed Web of Science ®Google Scholar
• Rydzewska L, Tierney J, Vale CL, et al. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database Syst Rev. 2012;12(12):CD007406. doi:10.1002/14651858.CD007406.pub323235641
   PubMed Web of Science ®Google Scholar
• Marita A, Ordeanu C, Rancea A, et al. Long-term survival following neoadjuvant chemotherapy and concomitant radiochemotherapy in locally advanced cervical cancer: results of the oncology institute “Prof. Dr. Ion Chiricuta” experience. J Med Life. 2018;11(1):42–50.29696064
   PubMedGoogle Scholar
• Kim YJ, Lee KJ, Park KR, et al. Prognostic analysis of uterine cervical cancer treated with postoperative radiotherapy: importance of positive or close parametrial resection margin. Radiat Oncol J. 2015;33(2):109–116. doi:10.3857/roj.2015.33.2.10926157680
   PubMedGoogle Scholar
• Dávila Fajardo R, van Os R, Buist MR, et al. Post-operative radiotherapy in patients with early stage cervical cancer. Gynecol Oncol. 2014;134(1):52–59. doi:10.1016/j.ygyno.2014.04.04524784874
   PubMed Web of Science ®Google Scholar